Theseus Pharmaceuticals, Inc. (19) | Uncategorized (8)
Recent Contracts
-
Description of Registrants Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 10, 2022)
-
Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and Timothy P. Clackson
(Filed With SEC on September 15, 2021)
-
Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and William C. Shakespeare
(Filed With SEC on September 15, 2021)
-
Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and David C. Dalgarno
(Filed With SEC on September 15, 2021)
-
Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and Victor M. Rivera
(Filed With SEC on September 15, 2021)
-
Offer Letter, dated September 10, 2021, by and between Theseus Pharmaceuticals, Inc. and Bradford D. Dahms
(Filed With SEC on September 15, 2021)
-
Offer Letter, dated May 25, 2021, by and between Theseus Pharmaceuticals, Inc. and Kathy Yi
(Filed With SEC on September 15, 2021)
-
Offer Letter, dated July 1, 2021, by and between Theseus Pharmaceuticals, Inc. and Iain D. Dukes
(Filed With SEC on September 15, 2021)